Literature DB >> 25488011

Low-grade sinonasal sarcoma with neural and myogenic features--diagnostic challenge and pathogenic insight.

Kathleen A Powers1, Lucy M Han2, Alexander G Chiu3, F Zahra Aly4.   

Abstract

A low-grade sinonasal sarcoma with neural and myogenic features has recently been defined and characterized. We present a case of this morphologic entity and discuss the differential diagnostic considerations, immunophenotypic character, electron microscopy (EM) findings and positron emission tomography (PET) appearance. We propose an alternative hypothesis of its origin on the basis of immunophenotypic and EM features. A 59-year-old Caucasian male was found to have a mass filling the right ethmoid sinus. On PET, the lesion had a maximum standardized uptake value of 2.9, which is of borderline intensity for sarcoma. Pathologic examination showed morphologic features similar to those reported for low-grade sinonasal sarcoma with neural and myogenic features. The tumor was positive for S100, β-catenin, caldesmon, and vimentin and negative for smooth muscle actin, muscle-specific actin, desmin, myogenin, and pankeratin. Positivity for β-catenin raises the alternative possibility of fibroblastic differentiation instead of the proposed myogenic differentiation. EM findings were also consistent with fibroblastic cells.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25488011     DOI: 10.1016/j.oooo.2014.10.007

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  9 in total

1.  Novel PAX3-NCOA1 Fusions in Biphenotypic Sinonasal Sarcoma With Focal Rhabdomyoblastic Differentiation.

Authors:  Shih-Chiang Huang; Ronald A Ghossein; Justin A Bishop; Lei Zhang; Tse-Ching Chen; Hsuan-Ying Huang; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2016-01       Impact factor: 6.394

Review 2.  Biphenotypic sinonasal sarcoma: demographics, clinicopathological characteristics, molecular features, and prognosis of a recently described entity.

Authors:  Simon Andreasen; Justin A Bishop; Henrik Hellquist; Jennifer Hunt; Katalin Kiss; Alessandra Rinaldo; Alena Skálová; Stefan M Willems; Michelle Williams; Alfio Ferlito
Journal:  Virchows Arch       Date:  2018-08-14       Impact factor: 4.064

Review 3.  New tumor entities in the 4th edition of the World Health Organization classification of head and neck tumors: Nasal cavity, paranasal sinuses and skull base.

Authors:  Lester D R Thompson; Alessandro Franchi
Journal:  Virchows Arch       Date:  2017-04-25       Impact factor: 4.064

4.  Biphenotypic Sinonasal Sarcoma-Case Report and Review of Clinicopathological Features and Diagnostic Modalities.

Authors:  Chandala Chitguppi; Ian Koszewski; Kaitlin Collura; Mark Curtis; Gurston Nyquist; Mindy Rabinowitz; Marc Rosen
Journal:  J Neurol Surg B Skull Base       Date:  2018-07-16

5.  Biphenotypic sinonasal sarcoma: an expanded immunoprofile including consistent nuclear β-catenin positivity and absence of SOX10 expression.

Authors:  Lisa M Rooper; Shih-Chiang Huang; Cristina R Antonescu; William H Westra; Justin A Bishop
Journal:  Hum Pathol       Date:  2016-04-29       Impact factor: 3.466

6.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Nasal Cavity, Paranasal Sinuses and Skull Base.

Authors:  Edward B Stelow; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2017-02-28

Review 7.  Newly Described Tumor Entities in Sinonasal Tract Pathology.

Authors:  Justin A Bishop
Journal:  Head Neck Pathol       Date:  2016-02-01

8.  Imaging and Outcomes for a New Entity: Low-Grade Sinonasal Sarcoma with Neural and Myogenic Features.

Authors:  Richard B Cannon; Richard H Wiggins; Benjamin L Witt; Yusuf Dundar; Tawni M Johnston; Jason P Hunt
Journal:  J Neurol Surg Rep       Date:  2017-01

9.  High-Grade Biphenotypic Sinonasal Sarcoma: A Case Report.

Authors:  Sukaina Hasnie; Chad Glenn; Jo E G Peterson; Edward T El Rassi; Kibwei A McKinney
Journal:  J Neurol Surg Rep       Date:  2022-09-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.